mRNA-LNP Encapsulation via Thermal Solution Exchange
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering messenger RNA (mRNA) using lipid nanoparticles are costly, time-consuming, and unpredictable, with low encapsulation efficiency and variable therapeutic outcomes.
Innovation Solution
A process involving mixing lipids with mRNA in a solution, followed by exchanging the solution and heating it to enhance encapsulation efficiency, using a pump system to form lipid nanoparticles with improved particle formation and scalability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional LNP formation processes are used, then mRNA encapsulation is achieved, but encapsulation efficiency is low and therapeutic outcomes are unpredictable
Solution Approach 1:
The patent applies parameter changes by modifying the physical state of the formulation solution through controlled heating. The heating step changes temperature parameters to optimize mRNA encapsulation within LNPs, transforming the formulation from a simple mixing process to a thermally-controlled encapsulation process that achieves higher efficiency and consistency
Solution Approach 2:
The patent implements preliminary action by performing solution exchange before the heating step. This preparatory action removes the LNP formation solution and replaces it with a drug product formulation solution, creating optimal conditions for the subsequent heating-induced encapsulation process
2Reliability
If novel lipids or particular lipid compositions are used to improve delivery, then intracellular delivery and mRNA expression may be affected, but the process becomes costly, time consuming and unpredictable
Solution Approach 1:
Instead of changing lipid compositions, the patent changes process parameters - specifically temperature and solution composition - to achieve improved encapsulation. This approach maintains manufacturing efficiency while achieving reliable delivery effectiveness through controlled heating and solution exchange steps
Solution Approach 2:
The patent substitutes complex lipid composition design with a simpler thermal processing approach. Rather than relying on novel lipid molecules to achieve encapsulation, the method uses controlled heating to drive encapsulation, replacing chemical complexity with physical process control
3Manufacturing precision
If the LNP formation solution is exchanged for a drug product formulation solution and heating is applied, then encapsulation efficiency is significantly increased, but process complexity increases
Solution Approach 1:
The patent applies extraction by removing the LNP formation solution and replacing it with a drug product formulation solution. This separation of formulation steps allows the heating step to be applied to a simplified system, achieving high encapsulation efficiency without requiring overly complex integrated processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process significantly increases mRNA encapsulation efficiency, leading to higher potency and efficacy of mRNA delivery, reducing costs and improving patient compliance with more effective protein expression across various administration routes.
Implementation Method 1
heating the mRNA-LNPs in the drug product formulation solution provide an unexpected benefit of significantly increasing the encapsulation efficiency
Data Source
AI summary
The present invention provides an improved process for lipid nanoparticle formulation and mRNA encapsulation. In some embodiments, the present invention provides a process for enhanced encapsulation of messenger RNA (mRNA) in lipid nanoparticles comprising a step of heating the mRNA-encapsulated lipid nanoparticles in a drug product formulation solution.